NextCure
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $3,282 | $0 |
Gross Profit | -633 | -654 | 1,641 | -700 |
EBITDA | -27,292 | -10,968 | -11,781 | -11,795 |
EBIT | -11,622 | -12,455 | -12,495 | |
Net Income | -26,808 | -10,976 | -11,603 | -11,540 |
Net Change In Cash | 0 | 0 | 3,282 | 0 |
Free Cash Flow | -22,713 | -12,994 | -6,935 | -11,624 |
Cash | 4,892 | 21,827 | 27,727 | 27,702 |
Basic Shares | 2,374 | 2,333 | 2,333 | 2,331 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,865 | -3,684 | -4,480 | -4,300 |
EBITDA | -54,341 | -59,039 | -71,785 | -65,012 |
EBIT | -57,206 | -62,723 | -75,909 | -69,312 |
Net Income | -55,654 | -62,723 | -69,433 | -69,389 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 14,293 | -23,908 | ||
Free Cash Flow | -41,279 | -53,794 | -56,002 | -59,604 |
Cash | 27,727 | 13,082 | 26,630 | 12,337 |
Basic Shares | 2,330 | 2,319 | 2,312 | 2,301 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$11.29 |
2025-03-31 | -$0.39 |
2024-12-31 | -$0.41 |
